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ABSTRACT
Introduction This study examines the feasibility of 
conducting diabetes- focused cognitive–behavioral 
therapy (CBT) via a secure online real- time instant 
messaging system intervention to support self- 
management and improve glycemic control in people 
with type 1 diabetes.
Research design and methods We used a pre–post 
uncontrolled intervention design over 12 months. We 
recruited adults with type 1 diabetes and suboptimal 
glycemic control (HbA1c ≥69 mmol/mol (DCCT 8.5%) 
for 12 months) across four hospitals in London. The 
intervention comprised 10 sessions of diabetes- focused 
CBT delivered by diabetes specialist nurses. The 
primary outcomes were number of eligible patients, 
rates of recruitment and follow- up, number of sessions 
completed and SD of the main outcome measure, 
change in HbA1c over 12 months. We measured 
the feasibility of collecting secondary outcomes, 
that is, depression measured using Patient Health 
Questionnaire-9 (PHQ-9), anxiety measured Generalised 
Anxiety Disorder (GAD) and the Diabetes Distress Scale 
(DDS).
Results We screened 3177 patients, of whom 638 were 
potentially eligible, from whom 71 (11.1%) were recruited. 
The mean age was 28.1 (13.1) years, and the mean HbA1c 
was 84.6 mmol/mol (17.8), DCCT 9.9%. Forty- six (65%) 
patients had at least 1 session and 29 (41%) completed all 
sessions. There was a significant reduction in HbA1c over 
12 months (mean difference −6.2 (2.3) mmol/mol, DCCT 
0.6%, p=0.038). The change scores in PHQ-9, GAD and 
DDS also improved.
Conclusions It would be feasible to conduct a full- scale 
text- based synchronized real- time diabetes- focused CBT 
as an efficacy randomized controlled trial.
INTRODUCTION
Around half of patients with type 1 diabetes 
do not achieve effective levels of glycemic 
control as recommended in National 
Institute for Health and Care Excellence 
guidance (UK standards)1 despite the wide-
spread access to interventions such as struc-
tured education and diabetes technologies 
which have an evidence base for improving 
HbA1c.2–4 One possible reason is that living 
with type 1 diabetes is associated with signifi-
cant psychological distress, the most common 
being depressive symptoms, anxiety and 
Significance of this study
What is already known about this subject?
 ► Around half of patients with type 1 diabetes do not 
achieve effective levels of glycemic control, and 
there is growing evidence of the efficacy of psy-
chological treatments in improving glycemic control 
in type 1 diabetes, but it remains unclear whether 
diabetes- focused cognitive–behavioral therapy 
(CBT) in the virtual setting can also lead to improved 
glycemic control.
What are the new findings?
 ► Online CBT for type 1 diabetes mellitus (T1DM) is an 
acceptable and feasible intervention for certain pa-
tients: in the context of COVID-19, it is very important 
to have access to effective treatments which may be 
delivered remotely.
 ► In those patients who are able to engage with the 
therapy, significant improvement in glycemic control 
was reported: mean (SD)=6.2 (2.3) mmol/mol.
 ► This suggests that this may be an important ad-
juvant treatment in the management of complex 
T1DM where glycemic control is suboptimal and 
may reduce the risk of developing complications of 
diabetes.
 ► There were trend improvements in symptoms of 
anxiety, depression or diabetes- related distress 
among participants who had elevated scores in 
measures of these symptoms at baseline.
How might these results change the focus of 
research or clinical practice?
 ► This provides evidence that a virtual approach to 
the delivery of diabetes- focused CBT may be suc-
cessful in empowering patients to optimize their 
diabetes management and improve their glycemic 
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diabetes- specific distress, which is associated with difficul-
ties in optimizing diabetes self- management, persistent 
hyperglycemia and higher risk of earlier onset of diabetes 
complications and premature mortality.5–9 Some patients 
experience stigma around their diabetes and changes 
in lifestyles, and these can accentuate this psychological 
distress.10 11
There is growing evidence of the efficacy of psycho-
logical treatments in improving glycemic control in 
type 1 diabetes.12 A multi- center randomized controlled 
trial (RCT) demonstrated that nurse- led motivational 
interviewing combined with basic cognitive–behavioral 
therapy (CBT) skills was more effective than usual care in 
improving glycemic control (mean difference in reduc-
tion in HbA1c=5.5 mmol/mol) in 340 adults with type 1 
diabetes and persistent suboptimal glycemic control.13 14 
However, it was not more cost- effective.15 One reason may 
be that the intervention was limited to patients who could 
attend face- to- face sessions in the participating hospitals. 
Patients on average completed 50% of the sessions and 
said that attending for mental health separate to diabetes 
care was time consuming, costly and burdensome.16
Psychological treatments using internet- based instant 
messaging systems offer an alternative to face- to- face 
therapy. In routine clinical practice, diabetes health 
professionals use the internet to access blood glucose 
(BG) data and give emotional and practical support via 
email and mobile texts and use mobile phone applica-
tions to support patients in carbohydrate counting and 
calculating insulin doses. There is evidence that these and 
other forms of telemedicine are effective in improving 
glycemic control,17 and that many patients prefer remote 
or virtual support to conventional therapy.18 19 Similarly, 
among patients with depression, an RCT of CBT deliv-
ered using a real- time online instant messaging system was 
more effective in improving depression scores than usual 
care.20 In patients with depression and type 1 diabetes, 
an RCT of online CBT focusing on depression reported 
significant improvement in depressive symptoms, but not 
in glycemic control.21 It appears therefore that where the 
primary focus of CBT is on diabetes self- management, it 
is more likely to lead to improved glycemic control in the 
face- to- face setting. However, it remains unclear whether 
CBT focusing on diabetes in the virtual setting can also 
lead to improved glycemic control.
The overall aim of this study was to test the feasibility 
of an online diabetes- focused CBT- based intervention 
in type 1 diabetes delivered by diabetes specialist nurses 
(DSNs). Specifically, we studied the following markers 
of feasibility: size of study population that was eligible, 
participation rates, uptake of sessions, and follow- up 
rates at 6 and 12 months.
MATERIALS AND METHODS
Participants
The target population was people with type 1 diabetes 
who have persistent hyperglycemia. The study inclusion 
criteria were adults patients aged ≥18 years with a diagnosis 
of type 1 diabetes based on hospital records, persistent 
hyperglycemia (HbA1c  ≥ 69 mmol/mol on at least two 
occasions for the past 12 months including the current 
status) and fluent in conversational English.
The exclusion criteria were those who had no access to 
the internet; required acute inpatient care for diabetes 
or unrelated medical conditions at recruitment; had a 
severe mental illness such psychotic disorder, substance 
dependence and learning difficulties; had major changes 
in insulin management (such as change in type of insulin 
or method of administration) or addition of oral diabetes 
medication in preceding 3 months; and were pregnant or 
planning pregnancy.
Design
This is a pre–post uncontrolled intervention study of a 
synchronic real- time online diabetes- focused CBT inter-
vention for people with type 1 diabetes over 12 months.
Setting
We screened the type 1 diabetes electronic databases 
in four secondary care diabetes clinics in the south 
east Thames region, UK: King’s College Hospital and 
Guy’s and St Thomas’s Hospital NHS Foundation Trusts 
and University Hospital Lewisham and Darent Valley 
Hospital, which combined serve a diverse socioeconomic 
and ethnic population of about 0.5 million residents.22
Measures
At baseline, we measured HbA1c (mmol/mol), dura-
tion of diabetes (years), and presence of macrovascular 
and microvascular diabetes complications using medical 
records. HbA1c was measured at 6 months and 12 months 
following recruitment as part of routine care.
We also measured three psychological constructs. 
We measured depressive symptoms using the Patient 
Health Questionnaire (PHQ-9),23 a 9- item self- report 
questionnaire (range 0 to 27) with a score ≥10 having 
a high specificity and sensitivity for depressive disorder. 
To assess symptoms of anxiety, we used the Generalised 
Anxiety Disorder 7- item scale (GAD-7),24 a 7- item self- report 
questionnaire (range 0–21) with two cut- offs: score ≥5 
and score ≥10 for subthreshold and threshold anxiety 
disorder, respectively.25–27 Diabetes- specific distress was 
measured using the Diabetes Distress Scale (DDS),28 a 
17- item self- report questionnaire based on four distress- 
related domains (emotional burden, physician- related 
distress, regimen- related distress and diabetes- related 
interpersonal distress) (range 17–51) and score of ≥40 
indicating clinically significant diabetes distress.29
Intervention
The intervention was titled Diabetes Online Therapy 
(DOT). It was delivered via a real- time instant messaging 
system using real- time text communication over the 
internet, accessible by phone or computer on the 
internet- based platform. A date and time were agreed 
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and conversed by typing in real time onto a shared plat-
form for the duration of the therapy session (private and 
secure internet chat room). Each session lasted 50 min. 
It is an NHS “Connecting for Health” registered plat-
form and thus fulfills NHS security and governance rules 
protecting patient confidentiality. The electronic plat-
form was provided by a commercial company that provides 
internet CBT for depression and anxiety commissioned 
by the NHS in parts of England.30 The DOT platform 
had functions to set up appointments, automatic tran-
scription of the session which can be shared by patient 
and therapist for secure communication outside sessions, 
chart progress using disease- specific measures, and to 
hold online and downloadable materials for guided self- 
help. At the end of each session, the therapist completed 
a brief summary outlining the main points of the session, 
along with the CBT homework agreed.
Participants were offered 10 sessions of CBT delivered 
over 3 months plus two follow- up sessions at monthly 
intervals. The therapy was delivered by five DSNs who 
received training in the basics of CBT from a consultant 
liaison psychiatrist qualified with a postgraduate diploma 
in CBT over 3 days, with subsequent role play sessions 
followed by feedback, and weekly supervision from a 
clinical psychologist trained in CBT over 6 months. We 
developed a diabetes CBT manual (available on request 
from authors) which was adapted and refined from an 
evidence- based face- to- face diabetes CBT manual.16 This 
formed the basis of self- directed learning and served 
to standardize the delivery of therapy across the nurse- 
therapists. The basic techniques that were taught included 
eliciting negative diabetes cognitions, basic 3- systems 
formulation, goal setting, agenda setting and feedback, 
activity scheduling, behavioral goals and experiments. 
The therapy was delivered by text, over the internet in 
real- time in 50 min sessions. While the DSN gave general 
advice about the management of type 1 diabetes, the 
specific diabetes care remained the responsibility of the 
local diabetes team to maintain patient safety.
Ethics
Informed consent by telephone was obtained from all 
participants, and a hard- copy signed consent was sent 
and received by mail.
Statistical analyses
All statistical analyses were performed using SPSS 
V.21.0.31 We reported baseline characteristics as mean 
and SD for continuous variables, and as proportions and 
percentages for categorical variables. We examined the 
changes in glycemic control within an individual from 
baseline to 6 months, and from baseline to 12 months 
using Student paired t- test. We conducted multivariate 
analysis with change in HbA1c as the dependent vari-
able, controlling for confounding factors, including age, 
gender and duration of diabetes. We examined change in 
the psychological measures from baseline to 12 months. 
A significance level of 5% was used throughout. A proxy 
marker for fidelity to the intervention was derived from 
the number of sessions attended and categorized into 
those who did not attend their first session, those who 
attended at least 1 or 2 sessions, and those who attended 
all 10 CBT sessions.
RESULTS
There were n=3177 patients on the clinical registers of 
the four participating hospitals. From this list, we identi-
fied n=638 patients who were potentially eligible because 
they met the inclusion criterion of at least 1 HbA1c  ≥
 69 mmol/mol in the past 12 months who were invited 
in writing by their clinician for further screening and 
consent. Of these, n=90 patients replied and n=71 (79%) 
consented to participate (figure 1). The majority were 
female and of White ethnicity, mean age was 28.1 (13.1) 
years and over half had a university degree. Mean dura-
tion of type 1 diabetes was 18.3 (10.3) years and mean 
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HbA1c was 84.6 (17.8) mmol/mol. While mean levels of 
depressive and anxiety symptoms were below diagnostic 
thresholds for their respective disorders, there were 
significant levels of diabetes- related distress (table 1).
Of the 71 people who consented, 25 (35.2%) did not 
attend their first online session; 17 (24%) attended either 
1 or 2 sessions and 29 (40.9%) completed all 10 sessions. 
Baseline data were collected on all individuals who 
consented to the study. Six- month and 12- month HbA1c 
data were collected for 27 (38%) and 36 (51%) patients, 
respectively. There were no significant differences in 
baseline demographic or clinical variables between those 
with and without 12- month HbA1c results (table 1, test 
statistics not shown). We observed a significant mean 
reduction in HbA1c from baseline to 12 months (table 2) 
of 6.2 (2.5) mmol/mol (p=0.038).
Twenty- two patients completed the psychological 
measures at 12 months. There was a non- significant mean 
reduction in scores for the PHQ-9 (mean difference-2.2 
(1.0), p=0.129), the GAD-7, (mean difference-4.3 (2.3), 
(p=0.031)) and in the DDS (mean difference-3.4 (1.7), 
p=0.37). There were no patients who scored ≥10 on 
the PHQ-9; therefore, we used the ≥5 cut- off for mild 
symptoms of anxiety. When we stratified patients into 
those with and without depressive or anxiety symptoms 
using cut- offs of PHQ-9 ≥5 and/or GAD-7 score ≥10, 
Table 1 Comparison of baseline characteristics by those with and without 12- month HbA1c data
Total at baseline 
(n=71)
Those with HbA1c data 
at 12 months (n=36)
Those with no HbA1c 
data at 12 months (n=35)
Age, mean (SD) 38.1 (13.1) 39 (12.5) 37.3 (13.9)
Gender, n (%)
  Male 17 (23.9) 8 (22.2) 9 (25.7)
  Female 54 (76.1) 28 (77.8) 26 (74.3)
Ethnicity, n (%)
  White 63 (92.6) 35 (94.4) 28 (87.5)
  Black, Asian, minority ethnic 5 (7.4) 1 (2.8) 4 (12.5)
Education, n (%)
  No examinations completed 2 (3.4) 1 (3.8) 1 (3.1)
  GSCEs/O- levels or equivalent 13 (22.4) 6 (23.1) 7 (21.9)
  A- levels or equivalent 13 (22.4) 8 (30.8) 5 (15.6)
  University degree or higher 30 (51.8) 11 (42.3) 19 (59.4)
Employment status, n (%)
  Employed full time 37 (63.8) 19 (70.4) 18 (58.1)
  Employed part time 7 (12.1) 2 (7.4) 5 (16.1)
  Sick leave, unemployed, homemaker 9 (15.5) 5 (18.5) 4 (12.9)
  Retired 2 (3.4) 1 (3.7) 1 (3.2)
  Student 3 (5.2) 0 (0) 3 (9.7)
Smoker, n (%) 14 (26.4) 7 (29.2) 7 (24.1)
Duration of diabetes in years, mean (SD) 18.3 (10.3) 16.6 (10.2) 20.2 (10.2)
Baseline HbA1c in mmol/mol, mean (SD) 84.6 (17.8) 83.3 (15.9) 85 (17.3)
Depressive symptoms at baseline (PHQ-9 score), mean (SD) 4.6 (3.3) 5.4 (4.1) 3.5 (3.5)
Anxiety symptoms at baseline (GAD-7 score), mean (SD) 4 (3.9) 5.3 (5.3) 5.3 (5.3)
Diabetes distress at baseline (DDS score), mean (SD) 48.2 (10.2) 44.6 (15.8) 44.9 (15.7)
At least mild symptoms (≥5) on PHQ-9 or GAD-7, n (%) 47 (66.2) 26 (72.2) 21 (60)
DDS, Diabetes Distress Scale; GAD-7, Generalised Anxiety Disorder 7- item scale (a measure of symptoms of anxiety); GSCE, General Certificate of Secondary Education; PHQ-9, 
Patient Health Questionnaire-9 (a measure of depressive symptoms).
Table 2 Changes in HbA1c and psychological measures over 12- month follow- up, in patients for whom there were follow- up 
data available (n=36)
Measure Baseline 12 months
Net change: baseline to 12 
months P value (paired t- test)
HbA1c, mmol/mol, mean (SD) (n=36) 84.6 (17.8) 78.4 (15.3) −6.2 0.038
PHQ-9 score, mean (SD) (n=22) 4.6 (3.3) 3.4 (2.2) −2.2 0.14
GAD-7 score, mean (SD) (n=22) 4 (3.9) 1.0 (1.6) −3.0 0.037
DDS score, mean (SD) (n=22) 48.2 (10.2) 37.8 (20.4) 10.4 0.225
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respectively, to include those with at least mild symp-
toms of depression or anxiety (n=22), there was a slightly 
greater improvement in glycemic control (table 3) and 
greater decrease in depressive and anxiety symptoms 
compared with those with subthreshold or no depressive 
or anxiety symptoms. Those with depressive or anxiety 
scores below these cut- offs at baseline showed a statisti-
cally significant mean increase in depressive symptoms, 
although the increased level was low (3.9), below the 
threshold for mild symptoms of depression and there-
fore unlikely to be of clinical significance. There were no 
significant differences in the change in glycemic control 
over 12 months stratified by the recruitment sites (results 
not shown).
When we stratified patients into those with and without 
depressive or anxiety symptoms using cut- offs of PHQ-9 
≥5 and/or GAD-7 score ≥5 to include those with all mild 
symptoms of depression or anxiety (n=27), there was 
a significant improvement in glycemic control (−5.3 
mmol/mol; p=0.038). There was a significant decrease 
in depressive symptoms (−3.3; p=0.037). The trend 
decreases in GAD and DDS, although clinically signif-
icant, were not statistically significant. There were no 
follow- up data for any participants who scored <5 on both 
PHQ-9 and GAD-7 at baseline.
We invited patients to give us verbal feedback and 
invited them to a feedback session following the end of 
the therapy. Patients described DOT as a “positive experi-
ence” and that the convenience was an important aspect 
of the therapy. They agreed that it was a flexible, acces-
sible mode of therapy and it was useful to have the tran-
script available between sessions. They reported that the 
therapist was approachable and empathic, despite being 
unable to see them. One patient who had had previous 
face- to- face therapy reported that it was easier to focus 
on conveying their thoughts and feelings, and to get 
their points across in the online setting. Another patient 
reported that the intervention was welcome but that it 
made them realize they needed even more help.
DISCUSSION
We conducted a feasibility study of online diabetes- 
focused CBT intervention for people with type 1 diabetes. 
The key findings were that the eligible population (those 
with persistent hyperglycemia defined as HbA1c  ≥ 69 
mmol/mol) was about 20% of all people with type 1 
diabetes. Of those who replied to our invitation, we had 
a high participation rate. We acknowledge that many 
patients did not reply to our invitation. We do not know 
all the reasons for this, which may include lack of access 
to internet and devices (which may reduce the acces-
sibility of this intervention), did not perceive that they 
may need psychological support, not willing to give the 
time commitment (which may also have been a barrier) 
and incorrect contact details. The target population is a 
particularly vulnerable group of patients with high levels 
of diabetes distress suggesting significant suffering, for 
whom conventional diabetes care pathways have not been 
effective in improving their glycemic control. This may 
reflect stigma and lack of knowledge about the impact of 
mental health on diabetes self- care and factors related to 
digital literacy. Around 65% of the patients participated 
in at least one session of therapy and 41% completed all 
10 sessions during the study period, suggesting reason-
able fidelity. This is in keeping with uptake rates for brief 
psychological interventions for depression and specifi-
cally in diabetes.30 31 This may reflect stigma and lack of 
knowledge about the impact of mental health on diabetes 
self- care and factors related to digital literacy.32
Preliminary estimates of effectiveness suggest a 
small but clinically significant reduction in HbA1c and 
improvement in psychological functioning. The sample 
did not have high levels of depressive or anxiety symp-
toms, but they did have high levels of diabetes distress. 
The attrition rate for follow- up of HbA1c at 12 months 
was around 50% which may be partly due to the study 
relying on routine HbA1c data collection in a population 
that struggles with self- care, which includes attending 
appointments. Paradoxically, DOT was developed to 
Table 3 Changes in HbA1c and psychological measures over 12- month follow- up in participants with PHQ-9 ≥5 or GAD-7 
≥10 (ie, at least mild symptoms of depression or anxiety) (n=22)
Measure Baseline 12 months
Net change:
baseline to 12 months P value
Those with at least mild symptoms (PHQ-9 ≥5 or GAD-7 ≥10)
  Baseline HbA1c, mmol/mol, mean (SD) 82.1 (17.7) 75.5 (13.9) −6.6 0.07
  Baseline PHQ-9 score, mean (SD) 6 (2.5) 4.3 (1.5) −1.7 0.129
  Baseline GAD-7 score, mean (SD) 5.8 (3.8) 1.5 (1.7) −4.3 0.031
  Baseline DDS score, mean (SD) 48.8 (11.3) 45.4 (9.6) −3.4 0.37
Those who did not have significant symptoms (PHQ-9 ≥5 or GAD-7 ≥10)
  Baseline HbA1c, mmol/mol, mean (SD) 95.4 (15.5) 91.1 (16.1) −4.3 0.18
  Baseline PHQ-9 score, mean (SD) 1 (1.2) 3.9 (5.2) +2.9 0.028
  Baseline GAD-7 score, mean (SD) 0.5 (0.7) 0 (0) −4.3 0.114
  Baseline DDS score, mean (SD) 48.8 (11.3) 45.4 (9.6) −3.4 0.5
Values in bold are those with a statistically significant (p<0.05) change from baseline to 12 months.
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make psychological interventions more accessible to 
those living in more remote areas and to reduce travel 
costs in this group who have long distances to travel for 
hospital appointments. This strategy of collecting routine 
data may need to be reconsidered in a full- scale RCT.
This improvement in glycemic control was comparable 
with other studies of psychological treatments to support 
diabetes self- management.33 An RCT of face- to- face CBT 
conducted by the same investigators observed a reduction 
in HbA1c of 5.5 mmol/mol.13 Our findings are compa-
rable with those of a feasibility RCT for people with type 
1 and type 2 diabetes comparing an online CBT program 
with therapist support provided by phone and email 
versus treatment as usual for depression,21 although the 
difference was that our inclusion criterion was suboptimal 
glycemic control, whereas in that study it was depressive 
symptoms and they included type 2 diabetes. In our 
study, those patients who had symptoms of depression 
or anxiety at baseline were the subgroup with significant 
improvements in glycemic control. Although this is an 
underpowered observation, it does suggest that people 
with suboptimal diabetes control in addition to psycho-
logical distress may be a target population for future 
diabetes- focused psychological interventions.
The strengths of this feasibility study include recruit-
ment of patients from teaching and non- teaching 
hospitals serving a diverse socioeconomic, ethnic and 
geographical populations. We were able to identify a suffi-
cient number of high- risk patients using routine hospital 
medical records, despite the absence of standardized 
type 1 diabetes registers. This study was the first that we 
are aware of to test online real- time text- based diabetes 
CBT integrated with type 1 diabetes care.
The limitations were that we did not measure alcohol 
or substance abuse, personality traits, illness perceptions, 
disordered eating or self- efficacy. We did this to mini-
mize patient burden while collecting data remotely but 
acknowledge that these may have been important predic-
tors of outcome. Some patients may have had higher 
levels of psychiatric morbidity for whom text- based CBT 
by a DSN may not be suitable and may explain why some 
patients did not respond to the invitation or the interven-
tion, as they may have needed more formal psychiatric 
care, consistent with patient feedback.
The uptake of online therapy was comparable with 
other studies, but there is scope for increasing this, 
especially in considering that around 50% of those 
recruited did not participate in therapy.34 As this was 
a virtual intervention, it was difficult to make contact 
with patients once they had dropped out; therefore, we 
were unable to ask about their reasons and also could 
not collect psychological outcomes. However, we were 
able to collect glycemic control outcomes from routine 
medical records. The aim of the DSN training was to 
minimize demands on nurse time while developing basic 
CBT skills. We did not measure the level of competencies 
in CBT. This is because this is a significant exercise in 
terms of costs and time which was outside the scope of 
this feasibility study. It requires qualified CBT therapists 
trained in conducting CBT rating scales and assessment 
of inter- rater reliability to assess reporting biases. Based 
on previous studies, it is likely they had beginner- level 
proficiency and it is possible that higher levels of profi-
ciency may have delivered better outcomes.35 There may 
have been dilution of CBT skills because the nurse may 
also have had to deliver diabetes education and nursing 
advice. However, formal training in generic CBT typically 
requires 1 year of full- time study which is prohibitive for 
the majority of diabetes professionals. This study demon-
strates that while it is feasible to train DSN in basic CBT, 
whether intensification of CBT training may improve the 
effectiveness of the intervention remains to be studied by 
using appropriate competency measures.
CONCLUSIONS
The improvements in glycemic control reported here 
was promising, especially when compared with previous 
psychological interventions designed at improving 
diabetes management in patients using psychological 
therapies. This suggests potential for both a diabetes- 
focused CBT and real- time text- based treatment modality, 
the efficacy of which will need further evaluation in RCT 
studies.
Author affiliations
1Psychiatry, University College Dublin, Dublin, Ireland
2Psychiatry, Mater Misericordiae University Hospital, Dublin, Ireland
3Department of Internal Medicine VI/Psychosomatic Medicine and Psychotherapy, 
University Hospital Tubingen, Tubingen, Baden- Württemberg, Germany
4Psychiatry, UCL, London, UK
5Diabetes, King’s College Hospital NHS Foundation Trust, London, UK
6Mental Health Research Unit, The University of Sheffield, Sheffield, UK
7Institute of Psychiatry, Psychology & Neuroscience, King’s College London, 
London, UK
Acknowledgements The authors would like to acknowledge the assistance 
of Ann Hayes of IESO Digital Health, our technological partners. We thank the 
participating Diabetes Centres and the people living with diabetes who were 
involved, and the five diabetes specialist nurses who volunteered their time to 
attend training and deliver the interventions.
Contributors AMD, KI, SW and AH- W planned the intervention. AH- W, KI and AMD 
wrote the treatment manual. AMD and AH- W trained and supervised the nurse- 
therapists. JB was involved in the delivery of the intervention. AR collected and 
managed the data. Data analysis was conducted by AR and AMD. This report was 
drafted by AMD, and all authors contributed to the writing and editing of the final 
paper.
Funding This study was funded by SBRI for the development of the technology 
(2013-10/62/03). Funding of the delivery of the intervention was obtained from the 
Health Foundation via their SHINE award (7309 CRM 1407).
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval This study received ethical approval from the NRES Committee 
London (Bromley) reference no 14- LO-0424.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available on reasonable request.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non- commercially, 






















































































































7BMJ Open Diab Res Care 2021;9:e001934. doi:10.1136/bmjdrc-2020-001934
Clinical care/Education/Nutrition
properly cited, appropriate credit is given, any changes made indicated, and the 
use is non- commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
ORCID iD
Anne M Doherty http:// orcid. org/ 0000- 0002- 6995- 5361
REFERENCES
 1 NICE. Type 1 diabetes in adults: diagnosis and management (2015). 
NICE guideline NG17 2016.
 2 The Diabetes Control and Complications Trial/Epidemiology of 
Diabetes Interventions and Complications (DCCT/EDIC) Study 
Research Group. Intensive diabetes treatment and cardiovascular 
disease in patients with type 1 diabetes. N Engl J Med 
2005;353:2643–53.
 3 McIntyre HD. DAFNE (Dose Adjustment for Normal Eating): 
structured education in insulin replacement therapy for type 1 
diabetes. Med J Aust 2006;184:317–8.
 4 Pollard DJ, Brennan A, Dixon S, et al. Cost- effectiveness of insulin 
pumps compared with multiple daily injections both provided 
with structured education for adults with type 1 diabetes: a health 
economic analysis of the Relative Effectiveness of Pumps over 
Structured Education (REPOSE) randomised controlled trial. BMJ 
Open 2018;8:e016766.
 5 Stahl- Pehe A, Glaubitz L, Bächle C, et al. Diabetes distress 
in young adults with early- onset type 1 diabetes and its 
prospective relationship with HbA
1c
 and health status. Diabet Med 
2019;36:836–46.
 6 Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of 
depression and distress in patients with diabetes: a call for greater 
clarity and precision. Diabet Med 2014;31:764–72.
 7 Johnson B, Eiser C, Young V, et al. Prevalence of depression among 
young people with type 1 diabetes: a systematic review. Diabet Med 
2013;30:199–208.
 8 Nuccitelli C, Valentini A, Caletti MT, et al. Sense of coherence, self- 
esteem, and health locus of control in subjects with type 1 diabetes 
mellitus with/without satisfactory metabolic control. J Endocrinol 
Invest 2018;41:307–14.
 9 Hagger V, Hendrieckx C, Sturt J, et al. Diabetes distress among 
adolescents with type 1 diabetes: a systematic review. Curr Diab 
Rep 2016;16:1–14.
 10 Brown JB, Valliere Y, McLachlan C, et al. Beyond the sick role: 
the many roles of adults with type 1 and type 2 diabetes in the 
management of hypoglycemia—The InHypo- DM Study, Canada. 
Can J Diabetes 2020;44:657–62.
 11 Ismail K, Stewart K, Ridge K, et al. A pilot study of an integrated 
mental health, social and medical model for diabetes care in an 
inner- city setting: Three Dimensions for Diabetes (3DFD). Diabet Med 
2020;37:1658–68.
 12 Winkley K, Ismail K, Landau S, et al. Psychological interventions 
to improve glycaemic control in patients with type 1 diabetes: 
systematic review and meta- analysis of randomised controlled trials. 
BMJ 2006;333:65.
 13 Ismail K, Thomas SM, Maissi E, et al. Motivational enhancement 
therapy with and without cognitive behavior therapy to treat type 1 
diabetes: a randomized trial. Ann Intern Med 2008;149:708–19.
 14 Maissi E, Ridge K, Treasure J, et al. Nurse- led psychological 
interventions to improve diabetes control: assessing competencies. 
Patient Educ Couns 2011;84:e37–43.
 15 Patel A, Maissi E, Chang H- C, et al. Motivational enhancement 
therapy with and without cognitive behaviour therapy for type 1 
diabetes: economic evaluation from a randomized controlled trial. 
Diabet Med 2011;28:470–9.
 16 Ridge K, Bartlett J, Cheah Y, et al. Do the effects of psychological 
treatments on improving glycemic control in type 1 diabetes persist 
over time? A long- term follow- up of a randomized controlled trial. 
Psychosom Med 2012;74:319–23.
 17 Faruque LI, Wiebe N, Ehteshami- Afshar A, et al. Effect of 
telemedicine on glycated hemoglobin in diabetes: a systematic 
review and meta- analysis of randomized trials. CMAJ 
2017;189:E341–64.
 18 Forbes A, While A, Griffiths P, et al. Organizing and delivering 
diabetes education and self- care support: findings of scoping 
project. J Health Serv Res Policy 2011;16:42–9.
 19 Ozcan S, Rogers H, Choudhary P, et al. Redesigning an intensive 
insulin service for patients with type 1 diabetes: a patient 
consultation exercise. Patient Prefer Adherence 2013;7:471–80.
 20 Kessler D, Lewis G, Kaur S, et al. Therapist- delivered Internet 
psychotherapy for depression in primary care: a randomised 
controlled trial. Lancet 2009;374:628–34.
 21 Newby J, Robins L, Wilhelm K, et al. Web- based cognitive 
behavior therapy for depression in people with diabetes mellitus: a 
randomized controlled trial. J Med Internet Res 2017;19:e157.
 22 Office for National Statistics. Regional ethnic diversity. London, 
2018. Available: https://www. ethnicity- facts- figures. service. gov. 
uk/ uk- population- by- ethnicity/ national- and- regional- populations/ 
regional- ethnic- diversity/ latest [Accessed 4 Jun 2019].
 23 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief 
depression severity measure. J Gen Intern Med 2001;16:606–1.
 24 Spitzer RL, Kroenke K, Williams JBW, et al. A brief measure for 
assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 
2006;166:1092–7.
 25 Swinson RP. The GAD-7 scale was accurate for diagnosing 
generalised anxiety disorder. Evid Based Med 2006;11:184.
 26 Plummer F, Manea L, Trepel D, et al. Screening for anxiety disorders 
with the GAD-7 and GAD-2: a systematic review and diagnostic 
metaanalysis. Gen Hosp Psychiatry 2016;39:24–31.
 27 Ahn J- K, Kim Y, Choi K- H. The psychometric properties and clinical 
utility of the Korean version of GAD-7 and GAD-2. Front Psychiatry 
2019;10:127.
 28 Polonsky WH, Fisher L, Earles J. Assessing psychosocial stress in 
diabetes. Diabetes Care 2005;28:626–31.
 29 Graue M, Haugstvedt A, Wentzel- Larsen T, et al. Diabetes- related 
emotional distress in adults: reliability and validity of the Norwegian 
versions of the Problem Areas in Diabetes Scale (PAID) and the 
Diabetes Distress Scale (DDS). Int J Nurs Stud 2012;49:174–82.
 30 Department of Health. IAPT three- year report: the first million 
patients. London: DoH, 2012.
 31 SPSS: IBM Corp. IBM SPSS statistics for Windows, version 21.0. 
Armonk, NY: IBM Corp, 2012.
 32 Esbitt SA, Batchelder AW, Tanenbaum ML, et al. "Knowing that 
you're not the only one": perspectives on group- based cognitive- 
behavioral therapy for adherence and depression (CBT- AD) in adults 
with type 1 diabetes. Cogn Behav Pract 2015;22:393–406.
 33 Winkley K, Upsher R, Stahl D, et al. Systematic review and 
meta- analysis of randomized controlled trials of psychological 
interventions to improve glycaemic control in children and adults 
with type 1 diabetes. Diabet Med 2020;37:735–46.
 34 van Ballegooijen W, Cuijpers P, van Straten A, et al. Adherence to 
Internet- based and face- to- face cognitive behavioural therapy for 
depression: a meta- analysis. PLoS One 2014;9:e100674.
 35 Ismail K, Winkley K, de Zoysa N, et al. Nurse- led psychological 
intervention for type 2 diabetes: a cluster randomised controlled trial 
(Diabetes-6 study) in primary care. Br J Gen Pract 2018;68:e531–40.
 o
n
 F
e
b
ru
a
ry
 1
7
, 2
0
2
1
 b
y
 g
u
e
s
t. P
ro
te
c
te
d
 b
y
 c
o
p
y
rig
h
t.
h
ttp
://d
rc
.b
m
j.c
o
m
/
B
M
J
 O
p
e
n
 D
ia
b
 R
e
s
 C
a
re
: firs
t p
u
b
lis
h
e
d
 a
s
 1
0
.1
1
3
6
/b
m
jd
rc
-2
0
2
0
-0
0
1
9
3
4
 o
n
 1
5
 J
a
n
u
a
ry
 2
0
2
1
. D
o
w
n
lo
a
d
e
d
 fro
m
 
